48 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
serves on the board of directors of Sorriso Pharmaceuticals, Inc. Dr. Sherman holds a B.A. in Biology from Lake Forest College and a M.D. from
8-K
fqh31lml enz3aoxub6m
3 Oct 23
Departure of Directors or Certain Officers
4:31pm
8-K
EX-99.2
v6qzahwsqbzj e8yje
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.1
ieq7d
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
EX-99.2
nloog6n23r
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
ey0mzi3yn3bvngsolmi
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
5acb7yco
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
c1c 0ijpg
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
5ysk5 pk2smy
28 Feb 22
Results of Operations and Financial Condition
8:16am